Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing
(NASDAQ: ANIX) Delayed: 2.77 -0.14 (4.81%)
Previous Close $2.91    52 Week High $ 
Open $2.97    52 Week Low $ 
Day High $2.97    P/E N/A 
Day Low $2.75    EPS $ 
Volume 285,078